AICHI MEDICAL UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1971-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
90
Active:0
Completed:43
Trial Phases
3 Phases
Phase 1:4
Phase 2:2
Not Applicable:84
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (90 trials with phase data)• Click on a phase to view related trials
Not Applicable
84 (93.3%)Phase 1
4 (4.4%)Phase 2
2 (2.2%)Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.
Phase 1
- Conditions
- Solid Tumor
- First Posted Date
- 2013-08-28
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Aichi Medical University
- Target Recruit Count
- 58
- Registration Number
- NCT01929486
- Locations
- 🇯🇵
Aichi Medical University, Nagoya, Aichi, Japan
News
No news found